79 related articles for article (PubMed ID: 2955931)
21. Apolipoprotein CII and lipoprotein lipase in human nephrotic syndrome.
Kashyap ML; Srivastava LS; Hynd BA; Brady D; Perisutti G; Glueck CJ; Gartside PS
Atherosclerosis; 1980 Jan; 35(1):29-40. PubMed ID: 7370086
[No Abstract] [Full Text] [Related]
22. Mechanisms of action of absorbable hypolipidemic drugs.
Sirtori CR
Adv Exp Med Biol; 1985; 183():241-52. PubMed ID: 4036700
[No Abstract] [Full Text] [Related]
23. Activation of lipoprotein lipase by apolipoprotein C-II is modulated by the COOH terminal region of apolipoprotein C-III.
Catapano AL
Chem Phys Lipids; 1987 Oct; 45(1):39-47. PubMed ID: 3446410
[TBL] [Abstract][Full Text] [Related]
24. Lipoprotein lipase activator deficiency in very low density lipoproteins in rat nephrotic syndrome.
Kashyap ML; de Mendoza SG; Campbell M; Chen CY; Lutmer RF; Glueck CJ
Experientia; 1978 Aug; 34(8):1044-5. PubMed ID: 212287
[TBL] [Abstract][Full Text] [Related]
25. Existence of lipoprotein lipase in rat brain microvessels.
Shirai K; Saito Y; Yoshida S; Matsuoka N
Tohoku J Exp Med; 1986 Aug; 149(4):449-50. PubMed ID: 3775767
[TBL] [Abstract][Full Text] [Related]
26. Activation of the enzymic activity of hepatic lipase by apolipoprotein A-II. Characterization of a major component of high density lipoprotein as the activating plasma component in vitro.
Jahn CE; Osborne JC; Schaefer EJ; Brewer HB
Eur J Biochem; 1983 Mar; 131(1):25-9. PubMed ID: 6403350
[No Abstract] [Full Text] [Related]
27. [HDL and atherosclerosis (author's transl)].
Loutan L
Schweiz Rundsch Med Prax; 1979 Aug; 68(35):1109-10. PubMed ID: 228262
[No Abstract] [Full Text] [Related]
28. [Role of the liver in the metabolism of lipoproteins].
Wang YJ; Wu BJ
Sheng Li Ke Xue Jin Zhan; 1990 Apr; 21(2):143-7. PubMed ID: 2205915
[No Abstract] [Full Text] [Related]
29. Further observations on the activation and inhibition of lipoprotein lipase by apolipoproteins.
Krauss RM; Herbert PN; Levy RI; Fredrickson DS
Circ Res; 1973 Oct; 33(4):403-11. PubMed ID: 4355035
[No Abstract] [Full Text] [Related]
30. Studies of synthetic peptide analogs of the amphipathic helix. Competitive displacement of exchangeable apolipoproteins from native lipoproteins.
Segrest JP; Chung BH; Brouillette CG; Kanellis P; McGahan R
J Biol Chem; 1983 Feb; 258(4):2290-5. PubMed ID: 6822560
[No Abstract] [Full Text] [Related]
31. Effect of heparin on the kinetics of guinea pig and human postheparin lipase activity.
Whayne TF; Bradford RH
Proc Soc Exp Biol Med; 1974 Feb; 145(2):595-603. PubMed ID: 4360646
[No Abstract] [Full Text] [Related]
32. [Endogenous hypertriglyceridemia].
Kotake H; Oikawa S
Nihon Rinsho; 2001 Mar; 59 Suppl 3():63-8. PubMed ID: 11347144
[No Abstract] [Full Text] [Related]
33. Lipoprotein lipase: molecular interactions of the enzyme.
Cryer A
Biochem Soc Trans; 1985 Feb; 13(1):27-8. PubMed ID: 3996739
[No Abstract] [Full Text] [Related]
34. Metabolic defect in type-III hyperlipoproteinaemia.
Ballantyne D; Ballantyne FC; Stromberg P
Lancet; 1977 Sep; 2(8037):556-7. PubMed ID: 95753
[No Abstract] [Full Text] [Related]
35. Defects of lipoprotein metabolism in familial combined hyperlipidaemia.
de Graaf J; Stalenhoef AF
Curr Opin Lipidol; 1998 Jun; 9(3):189-96. PubMed ID: 9645500
[TBL] [Abstract][Full Text] [Related]
36. Activation of lipoprotein lipase by synthetic fragments of apolipoprotein C-II.
Smith LC; Voyta JC; Catapano AL; Kinnunen PK; Gotto AM; Sparrow JT
Ann N Y Acad Sci; 1980; 348():213-23. PubMed ID: 6930927
[No Abstract] [Full Text] [Related]
37. Quantification of apolipoprotein C-II by immunochemical and chromatographic methods.
Connelly PW; Vezina C; Maguire GF
Methods Enzymol; 1996; 263():188-208. PubMed ID: 8749008
[No Abstract] [Full Text] [Related]
38. Metabolism of apolipoprotein C: kinetic studies in human subjects: a critical review.
Malmendier CL; Lontie JF; Grutman G; Delcroix C
Adv Exp Med Biol; 1987; 210():95-103. PubMed ID: 3296684
[No Abstract] [Full Text] [Related]
39. Antibodies of predetermined specificity to apolipoprotein C-II elicited with a synthetic peptide. Characterization and use for immunoassays.
Delpierre C; Fievet C; Equagoo V; Mezdour H; Cachera C; Gesquière JC; Tartar A; Fruchart JC
J Immunol Methods; 1988 Apr; 109(1):61-8. PubMed ID: 2451696
[TBL] [Abstract][Full Text] [Related]
40. Kinetics of heterogeneous populations of particles.
Malmendier GL; Lontie JF; Delcroix C; Dubois DY
Adv Exp Med Biol; 1991; 285():223-32. PubMed ID: 1858552
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
